The Advisory Team at Synklino provides expert guidance on scientific and strategic matters related to the development of the company's CMV-specific immunotoxin. Comprising scientific advisors and a senior strategic advisor, the team ensures that the company's efforts align with the latest scientific research and strategic business objectives.